Foot ulcerations in the setting of diabetes are difficult to manage conditions which can often lead to foot and/or...
Evolution of Kerecis™
Dermal substitutes or surrogates are a rapidly expanding area of medical technology. Absent of the morbidity and mortality associated with skin grafting, these products confer various benefits when attempting to heal or cover large soft tissue defects or slowly healing wounds. Research has demonstrated the ability of these products to recruit stem cells, decrease wound healing time, serve as scaffolds for eventual skin graft, and prevent future surgeries or procedures, all without donor site morbidity. Sources for these grafts vary from mammalian to fish and reptilian, and vary in size, composition, and anticipated use.
Kerecis Omega3™ is the first-ever fish-derived skin alternative. It is rich in fatty acids, and has the ability to recruit progenitor cells, allowing for it to ultimately be converted into living tissue. When compared to existing mammalian-based skin alternatives, Omega3 is cheaper, less harmful to produce, and has more promising clinical results. In addition, there is reduced risk of disease transmission, and the fish-based origin of the product carries with it less cultural constraint on usage. Traditional human, porcine or bovine skin substitutes require heavy processing in order to be prepared, which degrades the healing parameters of the graft.